MeiraGTx Holdings plc Increase (Decrease) in Deferred Liabilities
MeiraGTx Holdings plc (MGTX) reported Increase (Decrease) in Deferred Liabilities of -$65.19 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2019-11-07
- MeiraGTx Holdings plc increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was -$9.73K.
- MeiraGTx Holdings plc increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was -$13.37K, a 103.34% decline year-over-year.
- MeiraGTx Holdings plc increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was -$16.34K.
- MeiraGTx Holdings plc increase (decrease) in deferred liabilities for the quarter ending 2018-03-31 was -$25.76K.
- MeiraGTx Holdings plc increase (decrease) in deferred liabilities for fiscal 2018 was -$65.19K.
- MeiraGTx Holdings plc increase (decrease) in deferred liabilities for fiscal 2017 was -$324.02K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$9.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$23.09K derived: sum of 2 quarters · filed 2019-11-07 | -$39.43K derived: sum of 3 quarters · filed 2019-11-07 | -$65.19K 10-K · filed 2019-03-26 |
| 2018-09-30 | -$13.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$29.70K derived: sum of 2 quarters · filed 2019-11-07 | -$55.46K 10-Q · filed 2019-11-07 | -$1.56M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$16.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$42.09K 10-Q · filed 2019-08-07 | -$1.55M derived: sum of 3 quarters · filed 2019-08-07 | -$1.15M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$25.76K 10-Q · filed 2019-05-14 | -$1.53M derived: sum of 2 quarters · filed 2019-05-14 | -$1.13M derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$1.11M derived: sum of 2 quarters · filed 2019-03-26 | -$324.02K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $399.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.18M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $784.49K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |